Home  >  Products  >  MYCN (v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian)) Blocking Peptide (100ug)
MYCN (v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian)) Blocking Peptide (100ug)

MYCN (v-myc myelocytomatosis viral related oncogene, neuroblastoma derived (avian)) Blocking Peptide (100ug)

Supplier: Aviva Systems Biology Incorporated
Star_fadedStar_fadedStar_fadedStar_fadedStar_faded
0 reviews | Write a Review Pencil
This is a synthetic peptide designed for use in combination with anti-MYCN antibody (Catalogue #: ARP32030_T100) made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.
Presku: AAP32030
Size: 100 ug
Weight: 50kDa
Gene: 4613
Format: Lyophilized powder
Target: MYCN is a member of the MYC family and encodes a protein with a basic helix-loop-helix (bHLH) domain. It is located in the nucleus and must dimerize with another bHLH protein in order to bind DNA. Amplification of this gene is associated with a variety of tumors, most notably neuroblastomas
See Full Product Listings >